Drug Trial Radar · NCT00320099
Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock
Last checked: Nov 20, 2026Latest source record: Apr 6, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
508
Actual
Start
Jan 2006
Primary completion
Jan 2009
Study completion Feb 2009
Sponsor
- Lead sponsor
- University of VersaillesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Assistance Publique - Hôpitaux de Paris
- First posted
- May 3, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will compare, in adults with septic shock, the safety and efficacy of a combination of moderate doses of corticosteroids and intensive insulin therapy to that of moderate doses of corticosteroids. In addition, this study will compare the efficacy and safety of hydrocortisone alone versus hydrocortisone plus fludrocortisone
Conditions
- Septic Shock
Interventions
recombinant human insulinDrug
intensive insulin therapy as a continuous infusion to maintain blood glucose levels between 4 and 6 mmol/l
hydrocortisoneDrug
50 mg as iv bolus every 6 hours for 7 days
fludrocortisoneDrug
50 µg once a day via a nasogastric tube for seven days
HydrocortisoneDrug
hydrocortisone 50mg q6 for 7 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- In-hospital mortalityTime frame: Day 180
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Hôpital Avicenne
Bobigny, France
Hôpital Jean Verdier
Bondy, France
CHU Grenoble
Grenoble, France
Hôpital central
Nancy, France
Hôpital Saint Louis
Paris, France
Hôpital Bichat Claude Bernard
Paris, France
hôpital Cochin
Paris, France
Hôpital Delafontaine
Saint-Denis, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.